Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Philip T. Ninan, MD: Social Anxiety Disorder and the Neurobiology of Social Relationships
1
x
$
30.00
Ripu D. Jindal, MD: Effects of Tranylcypromine on the Sleep of Patients with Anergic Bipolar Depression
1
x
$
30.00
View Cart
Checkout
Home
The Next Step Forward: A Move Toward Evidence, and Away From Fear of the Industry
“Ripu D. Jindal, MD: Effects of Tranylcypromine on the Sleep of Patients with Anergic Bipolar Depression” has been added to your cart.
View cart
The Next Step Forward: A Move Toward Evidence, and Away From Fear of the Industry
$
0.00
The Next Step Forward: A Move Toward Evidence, and Away From Fear of the Industry quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 36 No. 4 Articles
Tags:
a-move-toward-evidence
,
editors-note
,
industry
,
michael-e-thase
Description
Description
Editor’s Note: The Next Step Forward: A Move Toward Evidence, and Away From Fear of the Industry – Michael E. Thase, MD
Related products
Ripu D. Jindal, MD: Effects of Tranylcypromine on the Sleep of Patients with Anergic Bipolar Depression
$
30.00
Add to cart
Details
Mikael Landén, MD, PhD: A Model to Explain the Therapeutic Effects of Serotonin Reuptake Inhibitors: The Role of 5-HT2 Receptors
$
30.00
Add to cart
Details
Assessing Rates and Predictors of Tachyphylaxis
$
30.00
Add to cart
Details
A Systematic Review of Augmentation Strategies for Major Depressive Disorder
$
30.00
Add to cart
Details
Page load link
Go to Top
